focus -WSS

focus

author：focus 2025-08-12 11:28:09 - browse：674

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Change Healthcare outage fallout shows need for new oversight

entertainment

WSS

Twill hunts for pharma partner to market its depression app

Ebola: Gilead Sciences antiviral shows promise as new treatment

Male and female sex labels in research insufficient, scientists say

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Study: Hearing aids may slow cognitive decline in those at risk

President Biden's budget: Here's what you might have missed

Wikipedia

focus

leisure time

Bright Health sells Medicare Advantage business to Molina

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA seeking to stop procedures at two unregulated stem cell clinics

Jerome Adams on the need for new antivirals for Covid

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

New air purifier tech could be key to improving indoor air quality

Study: Hearing aids may slow cognitive decline in those at risk

Duchenne breakthrough therapy leaves behind pioneering families

Ebola: Gilead Sciences antiviral shows promise as new treatment

focus

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Medicare coverage of Wegovy, once blocked, now looks possible

Change Healthcare outage fallout shows need for new oversight

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Study: Hearing aids may slow cognitive decline in those at risk

explore

focus

entertainment

hotspot